EHJ:“两大金刚”别嘌呤醇与苯溴马隆在痛风患者中的相关心血管风险

2021-09-12 MedSci原创 MedSci原创

痛风发作是疼痛剧烈的致失能性炎症性关节炎,通常累及单个关节,但有时也会累及2个或更多关节。

痛风发作是疼痛剧烈的致失能性炎症性关节炎,通常累及单个关节,但有时也会累及2个或更多关节。此时的治疗目标是迅速、安全地缓解疼痛和失能。即使不给予治疗,发作也通常会在数日到数周内完全缓解,特别是早期疾病。但很多抗炎药物都能加快症状缓解。

发作缓解后,患者进入无症状期(间期、间歇期或发作间期)。但大部分患者都会复发,随着发作频率的上升,症状可能会更加严重持久,而无症状期会缩短。反复发作的患者以及发展为慢性关节炎或痛风石的患者可使用降尿酸药物长期预防,以防痛风复发或发展为慢性痛风石性疾病。

有几类抗炎药物都能有效治疗痛风发作,包括全身用和关节内注射糖皮质激素、非甾体类抗炎药(NSAID)、秋水仙碱以及抑制IL-1β的生物制剂等。基本要求应达到“早治疗、早预防、降尿酸”的原则。

在发作期间继续降尿酸治疗–发作时已在接受降尿酸药物治疗(例如,别嘌醇、非布司他、丙磺舒、苯溴马隆或聚乙二醇重组尿酸酶)的患者应继续治疗,不要中断。暂停用药没有益处,并且停药一段时间后的复用可能会诱发痛风发作。

其中,别嘌醇和苯溴马隆是痛风患者降尿酸治疗的两大基石。随着痛风和相关心血管(CVD)疾病的高发病率,关于个别降尿酸药物的心血管安全性比较的信息变得越来越重要。然而,很少有研究对尿酸盐制剂的CVD风险进行研究。

为了比较了开始使用别嘌呤醇和苯溴马隆的痛风患者的CVD风险,来自韩国首尔国立大学盆塘医院内科风湿病科的专家开展了相关研究,结果发表在《欧洲心脏病杂志》EHJ上。

利用韩国国家健康保险索赔数据(2002-17年),研究人员对124434名痛风患者进行了队列研究,他们开始使用别嘌呤醇(n = 103695)或苯溴马隆(n = 20739),按5:1的比例进行倾向性评分匹配。主要结果是心肌梗死、中风/短暂性脑缺血发作或冠状动脉血运重建的复合CVD终点。为了考虑竞争性死亡风险,使用特定病因的危险模型来估计别嘌呤醇启动者与苯溴马隆的结果的危险比(HRs)和95%置信区间(CIs)。

在平均1.16年的随访中,2258名患者发生了复合型CVD事件。别嘌呤醇启动者的复合CV事件发生率(1.81/100人年)高于苯溴马隆(1.61/100人年),前者风险升高22%(HR=1.22,95%CI:1.05-1.41)。与苯溴马隆相比,别嘌呤醇启动者的全因死亡率则升高66%(HR=1.66,95% CI:1.43-1.93)。

别嘌醇与苯溴马隆使用患者K-M曲线

此外,与别嘌呤醇相比,苯溴马隆使用者的CVD合并症的发生率略高:心房颤动(4.2%对3.3%)、高血压(53.1%对49.3%)、慢性肾脏疾病(13.1%对9.2%)、血脂异常(43.5%对36.6%)和糖尿病(27.9%对26.4%)。苯溴马隆使用者的累积类固醇剂量也比别嘌呤醇使用者高。

苯溴马隆和别嘌呤醇使用者的Charlson-Deyo合并症评分(±标准差,SD)分别为1.62±1.81和1.51±1.83。在苯溴马隆使用者中,血脂水平(61.5% vs. 53.2%)、肾功能(62.1% vs. 54.6%)和尿酸水平(65.8% vs. 61.6%)的实验室检测更为频繁。

不同随访时间。别嘌醇与苯溴马隆使用患者CVD事件发生差异

综上,与苯溴马隆相比,别嘌呤醇与复合CVD事件和全因死亡的风险增加有关,苯溴马隆可能会降低痛风患者的CV风险和死亡率。

参考文献:

Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout, European Heart Journal, 2021;, ehab619, https://doi.org/10.1093/eurheartj/ehab619

评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2093039, encodeId=0f2b2093039f1, content=“两大金刚”<a href='/topic/show?id=3d6a323398d' target=_blank style='color:#2F92EE;'>#别嘌呤醇#</a>与<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>在<a href='/topic/show?id=69bbe11620e' target=_blank style='color:#2F92EE;'>#痛风#</a>患者中的相关<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>。只有<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>才是神药的侯选者, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32339, encryptionId=3d6a323398d, topicName=别嘌呤醇), TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆), TopicDto(id=71162, encryptionId=69bbe11620e, topicName=痛风), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险), TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Oct 11 03:39:31 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082567, encodeId=f0e2208256e56, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Sun Oct 31 19:12:24 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056081, encodeId=ddf8105608113, content=以前没有太关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Wed Sep 29 13:14:26 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052199, encodeId=c809105219908, content=秋水仙碱看过来, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/5785b262ac614e2787c8b09e8d8ae840/5cf1162cd10d42bc817ae4b32662d7f8.jpg, createdBy=c27d4938136, createdName=小小的丁香花, createdTime=Fri Sep 17 06:39:47 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295128, encodeId=ac26129512820, content=<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Sep 14 08:12:24 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050050, encodeId=ca50105005082, content=苯溴马隆, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Sep 13 21:15:27 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1017046, encodeId=948f101e046a2, content=未来可能还是看<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>它具有心血管保护作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Sep 13 15:02:16 CST 2021, time=2021-09-13, status=1, ipAttribution=)]
    2022-10-11 lifestar

    “两大金刚”#别嘌呤醇##苯溴马隆##痛风#患者中的相关#心血管风险#。只有#秋水仙碱#才是神药的侯选者

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2093039, encodeId=0f2b2093039f1, content=“两大金刚”<a href='/topic/show?id=3d6a323398d' target=_blank style='color:#2F92EE;'>#别嘌呤醇#</a>与<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>在<a href='/topic/show?id=69bbe11620e' target=_blank style='color:#2F92EE;'>#痛风#</a>患者中的相关<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>。只有<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>才是神药的侯选者, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32339, encryptionId=3d6a323398d, topicName=别嘌呤醇), TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆), TopicDto(id=71162, encryptionId=69bbe11620e, topicName=痛风), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险), TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Oct 11 03:39:31 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082567, encodeId=f0e2208256e56, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Sun Oct 31 19:12:24 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056081, encodeId=ddf8105608113, content=以前没有太关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Wed Sep 29 13:14:26 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052199, encodeId=c809105219908, content=秋水仙碱看过来, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/5785b262ac614e2787c8b09e8d8ae840/5cf1162cd10d42bc817ae4b32662d7f8.jpg, createdBy=c27d4938136, createdName=小小的丁香花, createdTime=Fri Sep 17 06:39:47 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295128, encodeId=ac26129512820, content=<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Sep 14 08:12:24 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050050, encodeId=ca50105005082, content=苯溴马隆, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Sep 13 21:15:27 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1017046, encodeId=948f101e046a2, content=未来可能还是看<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>它具有心血管保护作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Sep 13 15:02:16 CST 2021, time=2021-09-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2093039, encodeId=0f2b2093039f1, content=“两大金刚”<a href='/topic/show?id=3d6a323398d' target=_blank style='color:#2F92EE;'>#别嘌呤醇#</a>与<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>在<a href='/topic/show?id=69bbe11620e' target=_blank style='color:#2F92EE;'>#痛风#</a>患者中的相关<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>。只有<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>才是神药的侯选者, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32339, encryptionId=3d6a323398d, topicName=别嘌呤醇), TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆), TopicDto(id=71162, encryptionId=69bbe11620e, topicName=痛风), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险), TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Oct 11 03:39:31 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082567, encodeId=f0e2208256e56, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Sun Oct 31 19:12:24 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056081, encodeId=ddf8105608113, content=以前没有太关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Wed Sep 29 13:14:26 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052199, encodeId=c809105219908, content=秋水仙碱看过来, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/5785b262ac614e2787c8b09e8d8ae840/5cf1162cd10d42bc817ae4b32662d7f8.jpg, createdBy=c27d4938136, createdName=小小的丁香花, createdTime=Fri Sep 17 06:39:47 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295128, encodeId=ac26129512820, content=<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Sep 14 08:12:24 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050050, encodeId=ca50105005082, content=苯溴马隆, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Sep 13 21:15:27 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1017046, encodeId=948f101e046a2, content=未来可能还是看<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>它具有心血管保护作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Sep 13 15:02:16 CST 2021, time=2021-09-13, status=1, ipAttribution=)]
    2021-09-29 13f0c37dm61暂无昵称

    以前没有太关注。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2093039, encodeId=0f2b2093039f1, content=“两大金刚”<a href='/topic/show?id=3d6a323398d' target=_blank style='color:#2F92EE;'>#别嘌呤醇#</a>与<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>在<a href='/topic/show?id=69bbe11620e' target=_blank style='color:#2F92EE;'>#痛风#</a>患者中的相关<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>。只有<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>才是神药的侯选者, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32339, encryptionId=3d6a323398d, topicName=别嘌呤醇), TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆), TopicDto(id=71162, encryptionId=69bbe11620e, topicName=痛风), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险), TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Oct 11 03:39:31 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082567, encodeId=f0e2208256e56, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Sun Oct 31 19:12:24 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056081, encodeId=ddf8105608113, content=以前没有太关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Wed Sep 29 13:14:26 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052199, encodeId=c809105219908, content=秋水仙碱看过来, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/5785b262ac614e2787c8b09e8d8ae840/5cf1162cd10d42bc817ae4b32662d7f8.jpg, createdBy=c27d4938136, createdName=小小的丁香花, createdTime=Fri Sep 17 06:39:47 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295128, encodeId=ac26129512820, content=<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Sep 14 08:12:24 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050050, encodeId=ca50105005082, content=苯溴马隆, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Sep 13 21:15:27 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1017046, encodeId=948f101e046a2, content=未来可能还是看<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>它具有心血管保护作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Sep 13 15:02:16 CST 2021, time=2021-09-13, status=1, ipAttribution=)]
    2021-09-17 小小的丁香花

    秋水仙碱看过来

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2093039, encodeId=0f2b2093039f1, content=“两大金刚”<a href='/topic/show?id=3d6a323398d' target=_blank style='color:#2F92EE;'>#别嘌呤醇#</a>与<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>在<a href='/topic/show?id=69bbe11620e' target=_blank style='color:#2F92EE;'>#痛风#</a>患者中的相关<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>。只有<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>才是神药的侯选者, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32339, encryptionId=3d6a323398d, topicName=别嘌呤醇), TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆), TopicDto(id=71162, encryptionId=69bbe11620e, topicName=痛风), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险), TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Oct 11 03:39:31 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082567, encodeId=f0e2208256e56, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Sun Oct 31 19:12:24 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056081, encodeId=ddf8105608113, content=以前没有太关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Wed Sep 29 13:14:26 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052199, encodeId=c809105219908, content=秋水仙碱看过来, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/5785b262ac614e2787c8b09e8d8ae840/5cf1162cd10d42bc817ae4b32662d7f8.jpg, createdBy=c27d4938136, createdName=小小的丁香花, createdTime=Fri Sep 17 06:39:47 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295128, encodeId=ac26129512820, content=<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Sep 14 08:12:24 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050050, encodeId=ca50105005082, content=苯溴马隆, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Sep 13 21:15:27 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1017046, encodeId=948f101e046a2, content=未来可能还是看<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>它具有心血管保护作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Sep 13 15:02:16 CST 2021, time=2021-09-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2093039, encodeId=0f2b2093039f1, content=“两大金刚”<a href='/topic/show?id=3d6a323398d' target=_blank style='color:#2F92EE;'>#别嘌呤醇#</a>与<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>在<a href='/topic/show?id=69bbe11620e' target=_blank style='color:#2F92EE;'>#痛风#</a>患者中的相关<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>。只有<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>才是神药的侯选者, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32339, encryptionId=3d6a323398d, topicName=别嘌呤醇), TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆), TopicDto(id=71162, encryptionId=69bbe11620e, topicName=痛风), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险), TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Oct 11 03:39:31 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082567, encodeId=f0e2208256e56, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Sun Oct 31 19:12:24 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056081, encodeId=ddf8105608113, content=以前没有太关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Wed Sep 29 13:14:26 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052199, encodeId=c809105219908, content=秋水仙碱看过来, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/5785b262ac614e2787c8b09e8d8ae840/5cf1162cd10d42bc817ae4b32662d7f8.jpg, createdBy=c27d4938136, createdName=小小的丁香花, createdTime=Fri Sep 17 06:39:47 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295128, encodeId=ac26129512820, content=<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Sep 14 08:12:24 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050050, encodeId=ca50105005082, content=苯溴马隆, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Sep 13 21:15:27 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1017046, encodeId=948f101e046a2, content=未来可能还是看<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>它具有心血管保护作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Sep 13 15:02:16 CST 2021, time=2021-09-13, status=1, ipAttribution=)]
    2021-09-13 云舒

    苯溴马隆

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2093039, encodeId=0f2b2093039f1, content=“两大金刚”<a href='/topic/show?id=3d6a323398d' target=_blank style='color:#2F92EE;'>#别嘌呤醇#</a>与<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>在<a href='/topic/show?id=69bbe11620e' target=_blank style='color:#2F92EE;'>#痛风#</a>患者中的相关<a href='/topic/show?id=992151919e2' target=_blank style='color:#2F92EE;'>#心血管风险#</a>。只有<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>才是神药的侯选者, beContent=null, objectType=article, channel=null, level=null, likeNumber=171, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32339, encryptionId=3d6a323398d, topicName=别嘌呤醇), TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆), TopicDto(id=71162, encryptionId=69bbe11620e, topicName=痛风), TopicDto(id=51919, encryptionId=992151919e2, topicName=心血管风险), TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa0e14, createdName=lifestar, createdTime=Tue Oct 11 03:39:31 CST 2022, time=2022-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2082567, encodeId=f0e2208256e56, content=<a href='/topic/show?id=56658981223' target=_blank style='color:#2F92EE;'>#血管风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89812, encryptionId=56658981223, topicName=血管风险)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/78FA0899509C358B01B975E8EAC1F88A/100, createdBy=7d822500145, createdName=ms5353107019656438, createdTime=Sun Oct 31 19:12:24 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056081, encodeId=ddf8105608113, content=以前没有太关注。, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Wed Sep 29 13:14:26 CST 2021, time=2021-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052199, encodeId=c809105219908, content=秋水仙碱看过来, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210804/5785b262ac614e2787c8b09e8d8ae840/5cf1162cd10d42bc817ae4b32662d7f8.jpg, createdBy=c27d4938136, createdName=小小的丁香花, createdTime=Fri Sep 17 06:39:47 CST 2021, time=2021-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1295128, encodeId=ac26129512820, content=<a href='/topic/show?id=f1a68e07003' target=_blank style='color:#2F92EE;'>#苯溴马隆#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87070, encryptionId=f1a68e07003, topicName=苯溴马隆)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc52251, createdName=yhy100200, createdTime=Tue Sep 14 08:12:24 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1050050, encodeId=ca50105005082, content=苯溴马隆, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210814/61deb584a399410ca9b720adee4e6850/71825fee35134aee90c3ed9dfe89b69f.jpg, createdBy=3cff5430616, createdName=云舒, createdTime=Mon Sep 13 21:15:27 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1017046, encodeId=948f101e046a2, content=未来可能还是看<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>它具有心血管保护作用, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74767, encryptionId=10d5e476742, topicName=秋水仙碱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Sep 13 15:02:16 CST 2021, time=2021-09-13, status=1, ipAttribution=)]
    2021-09-13 病毒猎手

    未来可能还是看#秋水仙碱#它具有心血管保护作用

    0

相关资讯

治痛风靠戒口?专家说性价比太低了,千万别学

十年前痛风还是40岁以上的人群才会得的病,而现在低龄痛风患者越来越多,接诊过最年轻的痛风患者才14岁。

Arthritis Rheumatol:阿那白滞素治疗痛风发作的疗效和安全性

阿那白滞素是通过基因重组技术产生的人白介素1受体拮抗剂。阿那白滞素(anakinra)目前已被批准用于治疗系统性青少年特发性关节炎和成人Still病。

痛风患者的一个细节引起医生注意,结果竟查出心梗!

心梗早期发病可能比较隐匿,很多患者在初期不太在意,但事实上很凶险,心肌一旦大面积梗死,会引发呼吸、心跳骤停而死亡。

Am J Med:伴或不伴痛风的高尿酸血症患者,dotinurad VS. benzbromarone的疗效

高尿酸血症是尿酸盐沉积疾病(如尿石症和痛风性关节炎)的致病因素。Benzbromarone是日本最常用的尿毒症药物,但是因其严重的肝功能损害,很少有其他国家使用。Dotinurad是一种新型的选择性尿

痛风患者降尿酸药物的选择

几种促尿酸排泄药物和黄嘌呤氧化酶抑制剂(XOI)是非常有效的降尿酸盐药物,它们可使患者血尿酸水平恢复正常,最终减少或消除痛风发作,并预防或溶解痛风石。

Am J Clin Nutr:膳食宏量营养素对血清尿酸盐的影响:OmniHeart试验的结果

长期以来,饮食一直被认为是高尿酸血症和痛风发病机理中一个重要的可改变因素。预防痛风的膳食建议传统上强调减少富含嘌呤的食物(如肉类、海鲜和富含嘌呤的蔬菜)的摄入量,因为嘌呤是嘌呤清除途径中尿酸盐的前体。

拓展阅读

Rheumatology (Oxford):强化达标治疗提升痛风患者 5 年治疗依从性

接受强化达标治疗的痛风患者5年自我报告依从性较高(中位MARS-5=24),但非依从性(26.6%)与更频繁的发作及更低的sUA达标率显著相关。

痛风到底能不能吃豆制品?终于有了解释!

痛风患者常困惑豆类及豆制品摄入问题。虽豆类嘌呤含量高,但研究表明豆制品不会引发痛风,其促进尿酸排泄作用超嘌呤致血尿酸合成作用,还给出痛风及高尿酸血症饮食建议。

Arthritis Rheumatol:我国学者揭示肥胖患者体重减轻速率与痛风发病及复发的关系

在奥利司他治疗下,体重减轻速率与痛风发病及复发风险呈负相关。

ACR Open Rheumatol:Pegloticase联合甲氨蝶呤治疗以往单药治疗失败的痛风患者的疗效与安全性

对于曾经单药Pegloticase治疗失败的痛风患者,联合甲氨蝶呤的疗效较差,且IR发生率较高。

重大突破!白头翁苷B4精准打击痛风,揭秘其缓解关节炎的神秘力量!

文章探讨了B4在MSU诱导的急性痛风性关节炎中的治疗机制及其保护作用。

关于非布司他,你至少应该知道这6点!

目前,被广泛应用于临床降尿酸治疗。作为临床上防治痛风、高尿酸血症的一线药物,非布司他该如何正确地使用,又有哪些注意事项?关于非布司他,以下这6点你一定要知道!